The Chemours Co (LTS:0HWG)
$ 17.744 -0.0412 (-0.23%) Market Cap: 2.64 Bil Enterprise Value: 6.33 Bil PE Ratio: 36.00 PB Ratio: 4.01 GF Score: 66/100

Q3 2024 Chemours Co Earnings Call Transcript

Nov 04, 2024 / 01:00PM GMT
Release Date Price: $20.49 (+14.99%)

Key Points

Positve
  • The Chemours Co (CC) reported a 21% year-over-year increase in Opteon refrigerant sales, reflecting strong demand and market adoption.
  • The company achieved a record sales figure for its TSS business in the third quarter, driven by robust growth in Opteon refrigerants.
  • The TT business exceeded its year-to-date savings target, achieving $130 million in savings, surpassing the $125 million goal.
  • Chemours has successfully remediated two of its four material weaknesses, showing progress in addressing control issues.
  • The company outlined a refreshed corporate strategy, 'Pathway to Thrive,' focusing on operational excellence, growth, portfolio management, and long-term strengthening.
Negative
  • The Chemours Co (CC) reported a net loss of $27 million for the third quarter, including a $56 million non-cash impairment charge.
  • Advanced Materials results were weaker than anticipated due to pricing conditions and a softer market environment.
  • The APM segment's adjusted EBITDA decreased by 43%, with a significant decline in EBITDA margin.
  • Freon refrigerant pricing pressures continue due to elevated HFC inventory levels in the United States.
  • The company anticipates a sequential decline in net sales and adjusted EBITDA for the fourth quarter due to typical seasonal trends.
Operator

Good morning. My name is Daniel and I will be your conference operator today. I would like to welcome everyone to the Chemours company third-quarter 2024 results conference call. Currently all participants are in listen-only mode. A question and answer session will follow the conclusion of the prepared remarks. I would like to remind everyone that this conference call is being recorded.

I would now like to hand the conference call over to Brandon Ontjes, Vice President of Investor Relations for Chemours. You may begin your conference.

Brandon Ontjes
Chemours Co - VP-Investor Relations

Good morning, everybody. Welcome to The Chemours company's third-quarter 2024 earnings conference Call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer; and our Chief Financial Officer, Shane Hostetter.

Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided on our website contain forward-looking statements and involve risks and uncertainties as described

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot